BRPI1007653A2 - "dispositivos para inalação de insumos medicinais e componentes dos mesmos" - Google Patents

"dispositivos para inalação de insumos medicinais e componentes dos mesmos"

Info

Publication number
BRPI1007653A2
BRPI1007653A2 BRPI1007653A BRPI1007653A BRPI1007653A2 BR PI1007653 A2 BRPI1007653 A2 BR PI1007653A2 BR PI1007653 A BRPI1007653 A BR PI1007653A BR PI1007653 A BRPI1007653 A BR PI1007653A BR PI1007653 A2 BRPI1007653 A2 BR PI1007653A2
Authority
BR
Brazil
Prior art keywords
inhalation
devices
components
medicinal products
medicinal
Prior art date
Application number
BRPI1007653A
Other languages
English (en)
Inventor
A Kelly Jean
M David Moses
A Jinks Philip
Iyer Suresh
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of BRPI1007653A2 publication Critical patent/BRPI1007653A2/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D5/00—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures
    • B05D5/08—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface
    • B05D5/083—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface involving the use of fluoropolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/38—Details of the container body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/002—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from unsaturated compounds
    • C08G65/005—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from unsaturated compounds containing halogens
    • C08G65/007—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from unsaturated compounds containing halogens containing fluorine
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/336—Polymers modified by chemical after-treatment with organic compounds containing silicon
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/10—Block or graft copolymers containing polysiloxane sequences
    • C09D183/12—Block or graft copolymers containing polysiloxane sequences containing polyether sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0222—Materials for reducing friction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0238—General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/34—Applying different liquids or other fluent materials simultaneously
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2350/00—Pretreatment of the substrate
    • B05D2350/60—Adding a layer before coating
    • B05D2350/63—Adding a layer before coating ceramic layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D3/00—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials
    • B05D3/14—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials by electrical means
    • B05D3/141—Plasma treatment
    • B05D3/142—Pretreatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
    • C08G77/24—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen halogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences
    • C08G77/46—Block-or graft-polymers containing polysiloxane sequences containing polyether sequences

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)
BRPI1007653A 2009-05-06 2010-05-06 "dispositivos para inalação de insumos medicinais e componentes dos mesmos" BRPI1007653A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17589809P 2009-05-06 2009-05-06
PCT/US2010/033853 WO2010129758A1 (en) 2009-05-06 2010-05-06 Medicinal inhalation devices and components thereof

Publications (1)

Publication Number Publication Date
BRPI1007653A2 true BRPI1007653A2 (pt) 2019-09-24

Family

ID=42361780

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1007653A BRPI1007653A2 (pt) 2009-05-06 2010-05-06 "dispositivos para inalação de insumos medicinais e componentes dos mesmos"

Country Status (7)

Country Link
US (1) US20120097159A1 (pt)
EP (1) EP2427278B1 (pt)
CN (1) CN102458690B (pt)
AU (1) AU2010245839B2 (pt)
BR (1) BRPI1007653A2 (pt)
CA (1) CA2760808A1 (pt)
WO (1) WO2010129758A1 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0721737D0 (en) * 2007-11-06 2007-12-19 3M Innovative Properties Co Medicinal inhalation devices and components thereof
US10410838B2 (en) 2009-05-06 2019-09-10 3M Innovative Properties Company Apparatus and method for plasma treatment of containers
WO2010129753A1 (en) 2009-05-06 2010-11-11 3M Innovative Properties Company Medicinal inhalation device
US8664323B2 (en) 2010-06-25 2014-03-04 3M Innovative Properties Company Fluorinated composition, method of coating the composition, and article thereby
FR2979214B1 (fr) * 2011-08-26 2014-04-25 Seb Sa Article comportant un revetement antiadhesif presentant des proprietes ameliorees d'adherence au support
US11497681B2 (en) 2012-02-28 2022-11-15 Corning Incorporated Glass articles with low-friction coatings
US10737973B2 (en) 2012-02-28 2020-08-11 Corning Incorporated Pharmaceutical glass coating for achieving particle reduction
AU2013226034C1 (en) 2012-02-28 2016-10-27 Corning Incorporated Glass articles with low-friction coatings
US9988174B2 (en) 2012-06-07 2018-06-05 Corning Incorporated Delamination resistant glass containers
US10273048B2 (en) 2012-06-07 2019-04-30 Corning Incorporated Delamination resistant glass containers with heat-tolerant coatings
US9034442B2 (en) 2012-11-30 2015-05-19 Corning Incorporated Strengthened borosilicate glass containers with improved damage tolerance
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
US10117806B2 (en) * 2012-11-30 2018-11-06 Corning Incorporated Strengthened glass containers resistant to delamination and damage
US9027877B1 (en) * 2014-04-10 2015-05-12 Google Inc. Filling apparatus for high-altitude balloons
CN106457305B (zh) 2014-05-22 2020-06-02 3M创新有限公司 涂覆工艺
WO2016037083A1 (en) 2014-09-05 2016-03-10 Corning Incorporated Glass articles and methods for improving the reliability of glass articles
US10065884B2 (en) 2014-11-26 2018-09-04 Corning Incorporated Methods for producing strengthened and durable glass containers
EP3150564B1 (en) 2015-09-30 2018-12-05 Corning Incorporated Halogenated polyimide siloxane chemical compositions and glass articles with halogenated polylmide siloxane low-friction coatings
US20190054010A1 (en) 2015-10-29 2019-02-21 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
AU2016343719B2 (en) 2015-10-30 2021-03-04 Corning Incorporated Glass articles with mixed polymer and metal oxide coatings
WO2018213244A1 (en) 2017-05-17 2018-11-22 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
EP3661577B1 (en) 2017-08-03 2023-03-01 Kindeva Drug Delivery L.P. Coating process
WO2019088129A1 (ja) * 2017-10-31 2019-05-09 ダイキン工業株式会社 硬化性組成物
JP7089189B2 (ja) * 2017-10-31 2022-06-22 ダイキン工業株式会社 硬化性組成物
FR3077013B1 (fr) * 2018-01-24 2023-12-15 Aptar France Sas Dispositif de distribution de produit fluide.
EP3801456A1 (en) 2018-06-07 2021-04-14 Kindeva Drug Delivery L.P. Fluticasone and vilanterol formulation and inhaler
US20210275439A1 (en) 2018-06-07 2021-09-09 Kindeva Drug Delivery L.P. Fluticasone and vilanterol formulation and inhaler
EP3807369B1 (en) 2018-06-12 2024-07-24 3M Innovative Properties Company Fluoropolymer compositions comprising fluorinated additives, coated substrates and methods
WO2019241186A1 (en) 2018-06-12 2019-12-19 3M Innovative Properties Company Fluoropolymer coating compositions comprising amine curing agents, coated substrates and related methods
EP3813797A4 (en) 2018-06-27 2022-03-30 Kindeva Drug Delivery L.P. TIOTROPIUM FORMULATION AND INHALER
EP3880169B1 (en) 2018-11-12 2025-07-23 Kindeva Drug Delivery L.P. Umeclidinium and vilanterol formulation and inhaler
KR20220098161A (ko) 2019-11-04 2022-07-11 쓰리엠 이노베이티브 프로퍼티즈 캄파니 에틸렌계 불포화 기 및 전자 공여체 기를 갖는 경화제를 포함하는 플루오로중합체 조성물, 및 그로 코팅된 기재
WO2021088198A1 (en) 2019-11-04 2021-05-14 3M Innovative Properties Company Electronic telecommunications articles comprising crosslinked fluoropolymers and methods
US12365528B2 (en) 2020-09-04 2025-07-22 Corning Incorporated Ultraviolet light-blocking coated pharmaceutical packages
EP4398881A1 (en) 2021-09-08 2024-07-17 Kindeva Drug Delivery L.P. Propellants for anticholinergic agents in pressurized metered dose inhalers
EP4673151A1 (en) 2022-03-01 2026-01-07 Kindeva Drug Delivery L.P. Metered dose inhalers and high-dose suspensions
EP4402192B1 (en) 2022-08-18 2025-07-02 10X Genomics, Inc. Droplet forming devices and methods having flourous diol additives
WO2024182686A1 (en) 2023-03-02 2024-09-06 Kindeva Drug Delivery L.P. Metered dose inhalers and solutions including cannabinoids in hfa-152a
EP4673113A1 (en) 2023-03-02 2026-01-07 Kindeva Drug Delivery L.P. Metered dose inhalers and solutions including cannabinoids in hfo-1234ze(e)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646085A (en) * 1970-09-24 1972-02-29 Du Pont Perfluoroalkyletheramidoalkyltrialkoxysilanes
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
MX9707864A (es) 1995-04-14 1997-11-29 Glaxo Wellcome Inc Inhalador de dosis medida por salmeterol.
DE69637257T2 (de) 1995-04-14 2008-06-12 Smithkline Beecham Corp. Verfahren zur Herstellung eines Dosierinhalators
SK284448B6 (sk) 1995-04-14 2005-04-01 Glaxo Wellcome Inc. Merací dávkovací inhalátor
EA000889B1 (ru) 1995-04-14 2000-06-26 Глаксо Веллкам Инк. Дозирующий ингалятор дипропионата беклометазона
DK1208864T4 (da) 1998-02-23 2012-08-06 Glaxo Group Ltd Forbedringer til lægemiddelafgivelsesindretninger
EP1263491A2 (en) 2000-03-01 2002-12-11 Glaxo Group Limited Metered dose inhaler
WO2001064273A2 (en) 2000-03-01 2001-09-07 Glaxo Group Limited Metered dose inhaler
US20030183223A1 (en) * 2000-03-01 2003-10-02 Hailey Andrew Mark Metered dose inhaler
AU2001256168A1 (en) 2000-03-01 2001-09-12 Glaxo Group Limited Metered dose inhaler
GB0025092D0 (en) 2000-10-13 2000-11-29 Glaxo Group Ltd Medicament dispenser
SE0004610D0 (sv) 2000-12-13 2000-12-13 Astrazeneca Ab Surface modification process
WO2003006181A1 (en) 2001-07-10 2003-01-23 3M Innovative Properties Company Coated medicinal inhalation devices and components method
GB0122725D0 (en) 2001-09-21 2001-11-14 Glaxo Group Ltd Drug dispensing components
EP1300433B1 (en) * 2001-10-05 2008-10-15 Shin-Etsu Chemical Co., Ltd. Perfluoropolyether-modified silane, surface treating agent, and antireflection filter
US6716534B2 (en) * 2001-11-08 2004-04-06 3M Innovative Properties Company Coating composition comprising a fluorochemical polyether silane partial condensate and use thereof
US6861149B2 (en) * 2001-11-27 2005-03-01 3M Innovative Properties Company Compositions for aqueous delivery of self-emulsifying fluorinated alkoxysilanes
CN1181081C (zh) * 2003-05-28 2004-12-22 中国科学院上海有机化学研究所 含氟混合环硅氧烷、制备方法及其用途
US7553514B2 (en) * 2006-08-28 2009-06-30 3M Innovative Properties Company Antireflective article
US7891636B2 (en) * 2007-08-27 2011-02-22 3M Innovative Properties Company Silicone mold and use thereof
GB0721739D0 (en) * 2007-11-06 2007-12-19 3M Innovative Properties Co medicinal inhalation devices and components thereof
CA2704985C (en) * 2007-11-06 2017-02-28 Philip A. Jinks Medicinal inhalation devices and components thereof

Also Published As

Publication number Publication date
EP2427278B1 (en) 2015-09-23
WO2010129758A1 (en) 2010-11-11
US20120097159A1 (en) 2012-04-26
AU2010245839B2 (en) 2014-01-16
CN102458690A (zh) 2012-05-16
CN102458690B (zh) 2014-08-13
CA2760808A1 (en) 2010-11-11
EP2427278A1 (en) 2012-03-14
AU2010245839A1 (en) 2011-11-24

Similar Documents

Publication Publication Date Title
BRPI1007653A2 (pt) "dispositivos para inalação de insumos medicinais e componentes dos mesmos"
IL222132B (en) Use of cannabidivarin for the preparation of medicaments for treating epilepsy or epileptic seizures
BRPI1007675A2 (pt) "dispositivo para inalação de insumos medicinais"
BR112012018947A2 (pt) composição farmacêutica para tratamento e\ou prevenção do cancêr
IL236221A (en) History of theophyridone and pharmacological preparations containing them for the treatment of diseases
HUE040307T2 (hu) Új oxintomodulin-származékok és azokat tartalmazó gyógyszerészeti készítmények elhízás kezelésére
BRPI1013640A2 (pt) composicao farmaceutica, metodos para o tratamento e usos dos mesmos
EP2132133A4 (en) RELEASE OF PARTICULATE ACTIVE SUBSTANCES
BRPI0920658A2 (pt) dispositivo de inalação e método de dispensar medicamento
PT3111927T (pt) Composições para administração respiratória de agentes ativos e métodos e sistemas associados
PL2464342T3 (pl) Formulacje farmaceutyczne do zapobiegania niewłaściwemu użyciu leków medycznych
PT2355851T (pt) Novos lípidos e composições para a administração de agentes terapêuticos
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
DK3064579T3 (da) Farmaceutiske sammensætninger og medicinske anvendelsesformer af konstruerede humane arginaser
FI20135146L (fi) Farmaseuttiset koostumukset ja hoitomenetelmät
BRPI1015124A2 (pt) compostos aromáticos substituídos e usos farmacêuticos dos mesmos
PT2236149E (pt) Composição medicinal para o tratamento de doenças infeciosas respiratórias
GB2548034B (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
BRPI1006040A2 (pt) uso de composições farmacêuticas, tipo de curativo médico, e, tipo de caixa de medicamento
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
PL2582366T3 (pl) Kombinacja farmaceutyczna do leczenia bólu
BR112012002265A2 (pt) composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios
BRPI1009781A2 (pt) compostos para o tratamento de distúrbios metabólicos, composição farmacêutica que os compreende e uso dos mesmos
BR112012000303A2 (pt) antagonistas da via hedgehog e aplicações terapêuticas dos mesmos

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.